{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"212"}],"units":"Participants"}],"description":"Determine the incidence of transplant-related mortality at 6 months after UCBT","groups":[{"description":"Patients undergoing unrelated umbilical cord blood transplantation (UCBT) for hematologic malignancies treated with myeloablative preparative regimen comprising fludarabine phosphate, mycophenolate mofetil, filgrastim, cyclophosphamide, cyclosporine and fractionated total-body irradiation.","id":"OG000","title":"Unrelated UCBT for Blood Cancers"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"At Month 6","title":"Number of Participants Who Died Due to Transplant","type":"SECONDARY","unitOfMeasure":"Participants"}